share_log

Berenberg Cuts Novo Nordisk's Price Target After 'Disappointing' Weight-loss Drug Trial Results

Berenberg Cuts Novo Nordisk's Price Target After 'Disappointing' Weight-loss Drug Trial Results

貝倫貝格在諾和諾德的減肥藥物試驗結果「令人失望」後,降低了其股票目標價。
MT Newswires ·  01/06 23:27  · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論